Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Kite Pharma
Kite Pharma
Kite Hits 52-Week High on Positive Study
Investopedia
Wed, 03/1/17 - 11:30 am
Kite Pharma
KTE-C19
non-Hodgkin's lymphoma
Kite Pharma reports positive results from non-Hodgkins lymphoma drug study
Marketwatch
Tue, 02/28/17 - 11:08 am
Kite Pharma
non-Hodgkins lymphoma
KTE-C19
CAR-T
Kite Pharma partners with Japan's Daiichi for cancer therapy
Yahoo/Reuters
Tue, 01/10/17 - 11:11 am
Kite Pharma
Japan
Daiichi Sankyo
axicabtagene ciloleucel
CAR-T
Biotech Stocks: What to Watch in 2017
Motley Fool
Sun, 01/1/17 - 11:33 am
biotech
Seattle Genetics
Exelixis
Clovis Oncology
Kite Pharma
Juno Therapeutics Defeats Kite Pharma’s Challenge to CAR T-Cell Patent
Yahoo
Mon, 12/19/16 - 11:41 am
Juno Therapeutics
Kite Pharma
CAR-T
patents
3 Drugs Heading to the FDA Soon
Motley Fool
Mon, 12/12/16 - 09:34 am
FDA
Kite Pharma
KTE-C19
Flexion
Zilretta
AG-221
Agios Pharmaceuticals
Celgene
3 Big Advances In Cancer Treatment In 2016
Motley Fool
Mon, 12/12/16 - 09:24 am
cancer
Merck
Keytruda
Kite Pharma
KTE-C19
Ariad Pharmaceuticals
brigatinib
The 3 Best Biotech Stocks for 2017
Motley Fool
Fri, 12/9/16 - 09:23 am
biotech
biotech stocks
Celgene
Ionis Pharmaceuticals
Kite Pharma
Kite, Juno Cancer Data Fuel Price Dip
Investopedia
Thu, 12/8/16 - 10:05 am
Kite Pharma
Juno Therapeutics
CAR-T
non-Hodgkins lymphoma
Novartis Makes Its Case For Driving A CAR Into The Real World
Seeking Alpha
Mon, 12/5/16 - 10:43 pm
Novartis
CAR-T
Kite Pharma
CTL019
KTE-C19
Kite adds promising leukemia responses in small CAR-T studies, then fires the starting gun on its rolling submission
Endpoints
Mon, 12/5/16 - 10:01 am
Kite Pharma
CAR-T
clinical trials
KTE-C19
acute lymphoblastic leukemia
Kite Pharma Is Ready To Soar
Seeking Alpha
Fri, 11/25/16 - 09:16 am
Kite Pharma
KTE-C19
3 Potential Acquisition Targets for Gilead Sciences, Inc.
Motley Fool
Wed, 11/16/16 - 10:00 pm
Gilead Sciences
Kite Pharma
Tesaro
Intercept Pharma
M&A
Kite Pharma to keep anticipated CAR-T launch 'controlled' and targeted at certain hospitals
Medical Marketing and Media
Wed, 11/16/16 - 09:59 am
Kite Pharma
CAR-T
KTE-C19
diffuse large B-cell lymphoma
Kite Pharma Details KTE-C19 Launch Preparedness and Near-Term, Next Generation CAR/TCR Product Candidates at Investor Day
Yahoo
Thu, 10/20/16 - 09:17 am
Kite Pharma
KTE-C19
CAR-T
non-Hodgkin's lymphoma
Following Kite Pharma's Positive Top-Line Data, Focus Turns To Commercial Outlook
Yahoo/Benzinga
Sat, 10/8/16 - 03:46 pm
Kite Pharma
clinical trials
KTE-C19
CAR-T
refractory lymphoma
Kite Pharma Claims CAR-T Trial Victory, FDA Filing Next
TheStreet.com
Tue, 09/27/16 - 09:56 am
Kite Pharma
CAR-T
FDA
KTE-C19
diffuse large B-cell lymphoma
After Losing Medivation, Who Is Gilead Going After Next?
Forbes
Mon, 09/19/16 - 03:39 pm
Medivation
Gilead Sciences
M&A
Puma Biotechnology
Kite Pharma
Incyte
Portola Pharmaceuticals
10 Must-Know Biotech Stock Events to Close Out 2016
TheStreet.com
Fri, 09/9/16 - 09:04 pm
biotech
Eli Lilly
solanezumab
Biogen
aducanumab
Kite Pharma
KTE-C19
Bluebird Bio
LentiGlobin
Sarepta Therapeutics
eteplirsen
Ophthotech
Fovista
Bristol-Myers Squibb
Opdvio
Acadia
Nuplazid
Celgene
GED-301
Gilead Sciences
M&A
3 Hottest Cancer Biotech Acquisition Targets After Medivation
Forbes
Tue, 09/6/16 - 11:11 pm
cancer
biotech
M&A
Puma Biotechnology
Jazz Pharmaceuticals
Kite Pharma
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »